KvasirAccelerator | The first utility-oriented, agnostic software platform for quantum-centric drug discovery

Summary
Humanity is exploring the limits of computing to solve the world’s biggest challenges with unprecedented speed and precision. While quantum hardware is being matured into a commercial technology, there is still no quantum software capable of addressing real business problems. Furthermore, quantum computing will inevitably exacerbate the complexity of current computational workflows for non-coding experts to extract knowledge. At Kvantify, we are developing Kvaser, the first platform-agnostic, explainable, customer-centric quantum software tool, to be operated by the end-user. With EIC funding, we will develop advanced algorithms for quantum chemistry and machine learning that will solve real-life drug R&D problems beyond the scope of classical resources. Kvaser will empower R&D scientists to run molecular and biochemical simulations on modern hardware with unmatched speed and accuracy, enabling high precision quantum chemistry calculations for efficient and accelerated drug discovery.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/190124924
Start date: 01-08-2023
End date: 31-07-2025
Total budget - Public funding: 4 497 453,75 Euro - 2 499 999,00 Euro
Cordis data

Original description

Humanity is exploring the limits of computing to solve the world’s biggest challenges with unprecedented speed and precision. While quantum hardware is being matured into a commercial technology, there is still no quantum software capable of addressing real business problems. Furthermore, quantum computing will inevitably exacerbate the complexity of current computational workflows for non-coding experts to extract knowledge. At Kvantify, we are developing Kvaser, the first platform-agnostic, explainable, customer-centric quantum software tool, to be operated by the end-user. With EIC funding, we will develop advanced algorithms for quantum chemistry and machine learning that will solve real-life drug R&D problems beyond the scope of classical resources. Kvaser will empower R&D scientists to run molecular and biochemical simulations on modern hardware with unmatched speed and accuracy, enabling high precision quantum chemistry calculations for efficient and accelerated drug discovery.

Status

SIGNED

Call topic

HORIZON-EIC-2023-ACCELERATOROPEN-01

Update Date

12-03-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon Europe
HORIZON.3 Innovative Europe
HORIZON.3.1 The European Innovation Council (EIC)
HORIZON.3.1.0 Cross-cutting call topics
HORIZON-EIC-2023-ACCELERATOR-01
HORIZON-EIC-2023-ACCELERATOROPEN-01 EIC Accelerator Open 2023